Genital herpes is a common sexually transmitted infection (STI) caused by the herpes simplex virus (HSV). Genital herpes can often be spread by skin-to-skin contact during sexual activity. Some people infected with the virus may have very mild symptoms or no symptoms, however, they may still be able to spread the virus. Other people have pain, itching and sores around the genitals or anus.
This research study is evaluating the safety and immune response of an investigational herpes vaccine to potentially help prevent genital herpes lesions.
The study may be an option if you:
· Are aged 18-55 years old
· Have a diagnosis of recurrent genital herpes
· Have had between 3 to 9 genital herpes recurrences in the last year.
Other criteria apply.
This research study will include 11 scheduled visits to the clinic site and 6 phone calls. Qualified participants may receive the vaccine and will receive study-related evaluations and care at no cost. Financial compensation will also be provided for time and travel expenses to qualified participants.
The study may be an option if you:
· Are aged 18-55 years old
· Have a diagnosis of recurrent genital herpes
· Have had between 3 to 9 genital herpes recurrences in the last year.
Other criteria apply.
This research study will include 11 scheduled visits to the clinic site and 6 phone calls. Qualified participants may receive the vaccine and will receive study-related evaluations and care at no cost. Financial compensation will also be provided for time and travel expenses to qualified participants.
Submit to learn more:
Please note: You may or may not benefit medically from taking part and you are able to opt out at anytime and do not have to give us a reason for doing so. Your primary care physician will be informed about your participation and all medical assessments that will be carried out as part of the study. If during screening any abnormal results are found your primary care physician will also be informed.